February 2019-Fort Washington, PA: Ashfield, part of UDG Healthcare plc, a global leader in commercialisation services for the pharmaceutical and healthcare industry, is pleased to announce the promotion of Al Pavucek to Senior Vice President and Global Chief Financial Officer, for Ashfield Commercial and Patient Solutions.
Al assumes this promotion from his position of Senior Vice President and Chief Financial Officer of Ashfield US. Now in a global role, Al will oversee the global financial matters for the Ashfield Commercial and Patient Solutions businesses, including strategy, financial controls, profitability, mergers and acquisitions.
Al is a seasoned leader, with over twenty-five years of financial experience leading strategic, financial and operations teams in the life sciences industry. He has led consolidations of global divisions, merger & acquisition activities, as well as divestitures and corporate restructurings, working with commercial outsourcing firms to serve many of the pharmaceutical industries top clients.
“I’m honoured and thankful for this promotion and a chance to assist Ashfield with its continued growth and success,” Al commented. “It is a pleasure to work with such a great company that is full of exceptional people and I’m looking forward to building a working relationship with my new divisional colleagues.”
“We are pleased to have promoted Al into this position,” added Julian Tompkins, President, Ashfield Commercial and Patient Solutions. “He brings drive, passion and core strengths to the role that will help us continue to grow our organisation and exceed our client’s needs.”
Al holds an MBA in Finance from Temple’s Fox School of Business and a Bachelor’s of Science in Accounting, also from Temple University. In addition, Al is a Fellow Alumnus of the Wharton School of Business at the University of Pennsylvania, an executive programme for business leaders.